|
Name |
1-Tetradecene
|
Molecular Formula | C14H28 | |
IUPAC Name* |
tetradec-1-ene
|
|
SMILES |
CCCCCCCCCCCCC=C
|
|
InChI |
InChI=1S/C14H28/c1-3-5-7-9-11-13-14-12-10-8-6-4-2/h3H,1,4-14H2,2H3
|
|
InChIKey |
HFDVRLIODXPAHB-UHFFFAOYSA-N
|
|
Synonyms |
1-TETRADECENE; 1120-36-1; Tetradec-1-ene; Tetradecene; n-Tetradec-1-ene; 1-Tetradecylene; alpha-Tetradecene; 1-butadecene; Neodene 14; .alpha.-Tetradecene; AI3-10509; Alkenes, C10-16 .alpha.-; CHEBI:77505; FW23481S7S; MFCD00008981; NSC-66434; 1-Tetradecene [Standard Material for GC]; 68855-58-3; 25608-58-6; CCRIS 3785; HSDB 1087; EINECS 214-306-9; NSC 66434; a-Tetradecene; UNII-FW23481S7S; Tetradecene-1; NSC66434; DSSTox_CID_7367; TETRADECENE [INCI]; EC 214-306-9; DSSTox_RID_78426; Alkenes, C14-18 alpha-; Alkenes, C14-20 alpha-; DSSTox_GSID_27367; 1-TETRADECENE [HSDB]; CHEMBL1892257; DTXSID4027367; 1-Tetradecene, analytical standard; BAA12036; ZINC1693893; EINECS 272-493-2; EINECS 272-494-8; Tox21_303051; LMFA11000329; 1-Tetradecene, >=97.0% (GC); 1-Tetradecene, technical grade, 92%; AKOS015904124; NCGC00164372-01; NCGC00257042-01; LS-14356; CAS-1120-36-1; CS-0314332; FT-0608312; T0087; J-002695; Q27147080
|
|
CAS | 1120-36-1 | |
PubChem CID | 14260 | |
ChEMBL ID | CHEMBL1892257 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 196.37 | ALogp: | 7.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 14 | QED Weighted: | 0.294 |
Caco-2 Permeability: | -4.654 | MDCK Permeability: | 0.00001340 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.258 |
30% Bioavailability (F30%): | 0.727 |
Blood-Brain-Barrier Penetration (BBB): | 0.723 | Plasma Protein Binding (PPB): | 99.10% |
Volume Distribution (VD): | 2.082 | Fu: | 1.60% |
CYP1A2-inhibitor: | 0.716 | CYP1A2-substrate: | 0.211 |
CYP2C19-inhibitor: | 0.542 | CYP2C19-substrate: | 0.126 |
CYP2C9-inhibitor: | 0.243 | CYP2C9-substrate: | 0.929 |
CYP2D6-inhibitor: | 0.222 | CYP2D6-substrate: | 0.4 |
CYP3A4-inhibitor: | 0.545 | CYP3A4-substrate: | 0.083 |
Clearance (CL): | 4.563 | Half-life (T1/2): | 0.118 |
hERG Blockers: | 0.083 | Human Hepatotoxicity (H-HT): | 0.01 |
Drug-inuced Liver Injury (DILI): | 0.043 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.958 | Carcinogencity: | 0.078 |
Eye Corrosion: | 0.994 | Eye Irritation: | 0.974 |
Respiratory Toxicity: | 0.352 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000573 | 0.930 | D05ATI | 0.582 | ||||
ENC000510 | 0.925 | D0Z5BC | 0.520 | ||||
ENC000425 | 0.870 | D0Z5SM | 0.516 | ||||
ENC000273 | 0.850 | D0O1PH | 0.472 | ||||
ENC000557 | 0.816 | D07ILQ | 0.471 | ||||
ENC000455 | 0.775 | D00AOJ | 0.427 | ||||
ENC000283 | 0.769 | D05QNO | 0.397 | ||||
ENC000607 | 0.729 | D00FGR | 0.386 | ||||
ENC000589 | 0.727 | D0Y8DP | 0.373 | ||||
ENC000276 | 0.711 | D0XN8C | 0.356 |